Efficacy and Safety of PHPV Fusion Factor Vaginal Gel (PHPV®) in Clearing Cervical Persistent High-Risk Human Papillomavirus Infection: A Randomized Controlled Clinical Trial.

Drug Des Devel Ther · 2026 · PMC13003961 · PMID 41868183

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

did not reach statistical significanceP =0.058so close (0.05 < p ≤ 0.1)

Adjusted analyses showed that PHPV was significantly superior to no treatment (RR 2.81, 95% CI 1.37–5.79, P =0.005), whereas the interferon vs control comparison did not reach statistical significance (RR 2.08, 95% CI 0.98–4.44, P =0.058).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.